Weiwei Han

Exploring the New Trial Data Protection Regime in China

Premarket clinical trials demand substantial investment, yet without data protection, generic applicants could rely on originator data to obtain approval, undermining innovation incentives. In May 2026, China’s National Medical Products Administration issued the Implementation Me...